In Re: lorazepam/cloraze v. Mylan Laboratories

District Court, District of Columbia·Decided October 24, 2012·No. Misc. No. 1999-0276·Published
In Re: lorazepam/cloraze v. Mylan Laboratories, (D.D.C. 2012).

In Re: lorazepam/cloraze v. Mylan Laboratories (In Re: lorazepam/cloraze v. Mylan Laboratories) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hertz Corp. v. Friend
559 U.S. 77 (Supreme Court, 2010)
McNutt v. General Motors Acceptance Corp.
298 U.S. 178 (Supreme Court, 1936)
Provident Tradesmens Bank & Trust Co. v. Patterson
390 U.S. 102 (Supreme Court, 1968)
Moor v. County of Alameda
411 U.S. 693 (Supreme Court, 1973)
Newman-Green, Inc. v. Alfonzo-Larrain
490 U.S. 826 (Supreme Court, 1989)
Kokkonen v. Guardian Life Insurance Co. of America
511 U.S. 375 (Supreme Court, 1994)
Caterpillar Inc. v. Lewis
519 U.S. 61 (Supreme Court, 1996)
Phoenix Consulting, Inc. v. Republic of Angola
216 F.3d 36 (D.C. Circuit, 2000)
Loughlin, Thomas P. v. United States
393 F.3d 155 (D.C. Circuit, 2004)
Mastro, Brian A. v. Potomac Elec Power
447 F.3d 843 (D.C. Circuit, 2006)
Novak v. Capital Management & Development Corp.
452 F.3d 902 (D.C. Circuit, 2006)
Rafic Saadeh v. Fawaz Farouki
107 F.3d 52 (D.C. Circuit, 1997)